A Study of Atezolizumab Administered in Combination With Bevacizumab and/or With Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Nab-paclitaxel
Related studies linked through entity extraction aliases.
A Study of LY2090314 and Chemotherapy in Participants With Metastatic Pancreatic Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Neoadjuvant Study of Nab-paclitaxel Plus Carboplatin in Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
M402 in Combination With Nab-Paclitaxel and Gemcitabine in Pancreatic Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Nanoparticle-based Paclitaxel vs Solvent-based Paclitaxel as Part of Neoadjuvant Chemotherapy for Early Breast Cancer (GeparSepto)
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Pertuzumab in Combination With Trastuzumab (Herceptin) and a Taxane in First-Line Treatment in Participants With Human Epidermal Growth Factor 2 (HER2)-Positive Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Neoadjuvant Treatment With Nab-paclitaxel for Patients With Stage II and III Luminal Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Nab-paclitaxel (Abraxane) With or Without Mifepristone in Patients With Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Gemcitabine+Nab-paclitaxel and FOLFIRINOX and Molecular Profiling for Patients With Advanced Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Nab-Paclitaxel in Treating Older Patients With Locally Advanced or Metastatic Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Primary Chemotherapy With Anthracycline Followed by Nab-paclitaxel and Trastuzumab
- Status
- COMPLETED
- Phase
- PHASE2
Gemcitabine + Nab-paclitaxel With LDE-225 (Hedgehog Inhibitor) as Neoadjuvant Therapy for Pancreatic Adenocarcinoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Nab-paclitaxel in Metastatic Breast Cancer Patients Failing Solvent Based Taxane (Tiffany)
- Status
- TERMINATED
- Phase
- PHASE2
Induction Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Tolerability Study of GSK1120212, a MEK Inhibitor, in Combination With Docetaxel, Erlotinib, Pemetrexed, Pemetrexed + Carboplatin, Pemetrexed + Cisplatin, or Nab-Paclitaxel
- Status
- COMPLETED
- Phase
- PHASE1
Nab-paclitaxel, Gemcitabine, and Bevacizumab in Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Panitumumab, Nab-paclitaxel and Carboplatin for HER2 Negative Inflammatory Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Erlotinib, Gemcitabine and Nab-Paclitaxel in Advanced Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Cyclosporine A in Combination With Nab-Paclitaxel in Patients With Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Evaluate Trastuzumab Plus Standard Chemotherapy Given Before Surgery in Breast Cancer Patients With Low HER 2 Expression
- Status
- COMPLETED
- Phase
- PHASE2